Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00488644 · ClinicalTrials.gov registry record · NA
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00488644: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT00488644 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00488644, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Primary Objectives: 1. Assess whether combined treatment with Levothyroxine and Liothyronine improves learning and memory. 2. Explore the relationship between T3 treatment and other domains of cognitive function, quality of life, and mood.
Interventions
- DRUG Levothyroxine
- DRUG Liothyronine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-02 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00488644
The ClinicalTrials.gov registry entry for NCT00488644 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Levothyroxine is the first listed.
NCT00488644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00488644 about?
NCT00488644 is a clinical study titled "Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors". Primary Objectives: 1. Assess whether combined treatment with Levothyroxine and Liothyronine improves learning and memory. 2. Explore the relationship between T3 treatment and other domains of cognitive function, quality of life, and mood.
What is the current status of trial NCT00488644?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2006-02. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00488644?
The interventions under investigation include: Levothyroxine (DRUG), Liothyronine (DRUG).
Who is sponsoring clinical trial NCT00488644?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.